Low-grade bone lesions in survivors of childhood medulloblastoma/primitive neuroectodermal tumor
- PMID: 22054800
- DOI: 10.1016/j.acra.2011.08.018
Low-grade bone lesions in survivors of childhood medulloblastoma/primitive neuroectodermal tumor
Abstract
Objectives and rationale: Medulloblastoma/primitive neuroectodermal tumor (MB/PNET) is the most common malignant tumor of the central nervous system (CNS) in children. MB/PNET survivors are at an increased risk for developing second malignancies. Little has been reported on development of low-grade lesions of the calvarium in the radiation field in MB/PNET survivors. The purpose of this study was to assess the frequency of the low-grade bone lesion development in the radiotherapy field in pediatric MB/PNET survivors and describe the imaging characteristics of these lesions.
Materials and methods: Institutional review board approval was obtained for this retrospective review which was compliant with Health Insurance Portability and Accountability Act. Forty-one MB/PNET patients (29 male) who survived for at least 2 years after initiation of radiation therapy were included. The medical records were reviewed. The most recent available brain magnetic resonance imaging studies were evaluated.
Results: Three patients (7.3%) developed low-grade calvarial lesions and underwent resection and/or biopsy of the lesions. There were one Langerhans cell histiocytosis, one benign spindle cell lesion with myxoid change, and one fibrous dysplasia.
Conclusion: Development of low-grade bone lesions of calvarium is not very rare in pediatric PNET/MB survivors. Bones in the radiation therapy field need to be carefully examined for assessment of secondary lesions.
Copyright © 2012 AUR. Published by Elsevier Inc. All rights reserved.
Similar articles
-
MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.Clin Cancer Res. 2001 Aug;7(8):2425-33. Clin Cancer Res. 2001. PMID: 11489822
-
White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.J Clin Oncol. 2004 Nov 15;22(22):4551-60. doi: 10.1200/JCO.2004.03.058. J Clin Oncol. 2004. PMID: 15542806 Clinical Trial.
-
Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.Clin Cancer Res. 1997 Mar;3(3):473-8. Clin Cancer Res. 1997. PMID: 9815707
-
In vivo and in vitro models of medulloblastomas and other primitive neuroectodermal brain tumors of childhood.Mol Chem Neuropathol. 1994 Feb-Apr;21(2-3):219-39. doi: 10.1007/BF02815352. Mol Chem Neuropathol. 1994. PMID: 8086035 Review.
-
[CNS primitive neuroectodermal tumor suspected as a secondary recurrence after radiation therapy for medulloblastoma:a case report].No Shinkei Geka. 2014 Jul;42(7):641-50. No Shinkei Geka. 2014. PMID: 25006105 Review. Japanese.
Cited by
-
Benign skull and subdural lesions in patients with prior medulloblastoma therapy.Childs Nerv Syst. 2021 Feb;37(2):359-366. doi: 10.1007/s00381-020-04874-2. Epub 2020 Sep 2. Childs Nerv Syst. 2021. PMID: 32876801 Review.
-
Treatment-related calvarial lesions in pediatric brain tumor survivors.Pediatr Blood Cancer. 2020 Jun;67(6):e28189. doi: 10.1002/pbc.28189. Epub 2020 Apr 14. Pediatr Blood Cancer. 2020. PMID: 32286018 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous